The workshop 'Research Needs for Neutron Capture Therapy', held in Wil
liamsburg, VA, May 9-12, 1995 addressed key issues and questions relat
ed to optimization of boron neutron capture therapy (BNCT), in general
, and to the possibility of success of the present BNCT trials at the
Brookhaven National Laboratory (BNL) and Massachusetts Institute of Te
chnology (MIT), in particular. Both trials use nuclear fission reactor
s as neutron sources for BNCT of glioblastoma multiforme (BNL) and of
deep seated melanoma (MIT). Presentations and discussions focussed on
optimal boron-labeled compounds, mainly for brain tumors such as gliob
lastoma multiforme, and the best mode of compound delivery to the tumo
r. Also, optimizing neutron irradiation with dose delivery to the tumo
r cells and the issues of dosimetry of BNCT especially in the brain we
re discussed. Planning of treatment and of follow-up of patients, coor
dination of BNCT at various treatment sites, and the potential of deli
very BNCT to various types of cancer with an appropriately tailored pr
otocol were additional issues. The need for multicentric interdiscipli
nary cooperation among the different medical specialties was highlight
ed.